| Senior results-oriented executive with extensive knowledge
of the pharmaceutical and biotechnology industries; substantial hands-on
experience and proven track record of significant accomplishments in several
functional areas such as: Strategic planning, rejuvenation of mature product
lines, quality and performance improvements, pre-commercial product development,
manufacturing and packaging, quality control and assurance, materials
control and purchasing, physical storage and distribution to domestic
and foreign markets.
SELECTED ACHIEVEMENTS
Strategic planning: Assigned, by the parent corporation, direct responsibility
for the preparation of the 5 year strategic plan on behalf of Squibb Canada
Inc. Actively participated, on behalf of the parent corporation, in the
formulation and implementation of counter-generic strategies.
Rejuvenation of mature product lines: Initiated, developed and brought
to market the award winning Uni-Vials (finalist in the Mercuriades, Gold
medal award in the U.S. for packaging innovations), initiated and developed
the Dosating Dispensor (metered dose of semi-solids) and initiated the
development of a pre-filled, single-use, unit-dose syringe with retractile
needle.
Quality and performance improvements: Reduced reject rate from 3.75% to
0.50% on parenteral product line, improved gross profit margins from 28%
to 41% on multi-source product line, reduced import tariffs on diagnostic
product line, sold obsolete and remnants raw and component materials,
exchanged process-obsolete equipment, rehabilitated and sold excess industrial
land. Initiated and implemented registration and regulatory approval of
pharmaceutical plants. Reviewed and edited the CMC section of submissions
destined for filing with Canadian and U.S. authorities. At time of merger
with Bristol-Myers, Squibb Canada was deemed to possess a 20% unit cost
advantage over their U.S. counterparts.
Pre-commercial product development: Planned, implemented, monitored and
controlled numerous pre-commercial development projects both working as
an executive of the company or as external advisor directing the efforts
of internal human and physical resources or those of multiple third parties.
Materials control and purchasing: Initiated and implemented MAPICS on
behalf of the Canadian entity and for subsequent use by sister companies
abroad, implemented on-line order entry, negotiated return and credit
for obsolete active pharmaceutical ingredients (API), negotiated return
of outdated product and chemical recovery of API, negotiated annual blanket
purchase orders with split deliveries covering all single-source component
and raw ingredients.
Physical storage and distribution to markets: Reduced number of storage
and distribution sites in Canada from 5 to 2, thereby lowering internal
and external operating costs and improving customer service levels. Introduced
next-day delivery across Canada for all orders received prior to 15:00
(EST).
PRIOR EXPERIENCE
Squibb Canada Inc. – Vice-President, Technical
operations
ICN Canada Inc. – Vice-President, Technical operations
Escar Pharma-Chem International Inc. – Founder
and President
Alliance Pharma (1996) Inc. – Founder and President
RTP Pharma Canada Inc. – Vice-President, Technical
operations
SkyePharma Canada Inc. – Vice-President, Technical
operations
QUALIFICATIONS
McGill University – Advanced Management Program: Executive Development
Program
Université de Montréal – Bsc (Honours, Physics) |
